NAD+ IV vs Injection vs Oral: A Practical Decision Framework for Patients

Choosing between NAD+ IV, injection, and oral options should be based on clinical fit, convenience, and physician-supervised monitoring—not hype. The right option depends on your goals, baseline health profile, and ability to follow through on care. ## Quick comparison - **IV NAD+**: often chosen when direct, in-clinic administration is preferred. - **NAD+ injection**: may fit patients who need structured but more flexible administration. - **Oral NAD+ support**: may be considered for lower-complexity routines depending on clinician guidance. ## Decision factors to discuss with your clinician 1. Primary goal (energy, recovery, healthy aging support) 2. Budget and visit logistics 3. Tolerance and side-effect monitoring plan 4. Follow-up cadence and lab strategy 5. Adherence likelihood over time ## Safety and quality guardrails - Use physician-supervised care and validated sourcing pathways. - Avoid self-directed protocol changes. - Reassess if expected response is not matched or adverse effects appear. ## What we know / what we don't ### What we know - Delivery method affects practicality, follow-through, and monitoring requirements. - Structured follow-up improves decision quality and safety. ### What we don't - There is no universally superior route independent of patient context. ## Related resources - NAD+ overview: https://newbluehealth.com/peptides/nad-plus - Evidence methodology: https://newbluehealth.com/evidence-methodology - Safety policy: https://newbluehealth.com/safety-policy - Medical review policy: https://newbluehealth.com/medical-review-policy *Educational content only. Not medical advice. Final decisions should be made with a licensed clinician.*

NAD+ IV vs Injection vs Oral: A Practical Decision Framework for Patients.